---
$id: https://graph.org.ai/products/commodity/51342603
$type: Product
source: UNSPSC
code: "51342603"
title: "Fomivirsen sodium"
class: "51342600"
classTitle: "Antiviral sulfur compounds"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Fomivirsen sodium

**UNSPSC Code**: 51342603
**Class**: [Antiviral sulfur compounds](Antiviral sulfur compounds.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antisense agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z6W3S36X5. European Medicines Agency schedules Fomivirsen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02253MIG. Fomivirsen sodium generally arises in the molecular formula C204H243N63O114P20S20.20NA. The term 'fomivirsen sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule fomivirsen sodium under HS 29349990 and SITC 51579. Fomivirsen sodium bears US NLM identifiers UMLS ID C0982166 and NCI Concept Code C61770. SMILES: As of Q4 2014, FOMIVIRSEN SODIUM remains US FDA's Preferred Term for this commodity.

